PEGylated d-serine dehydratase as a d-serine reducing agent

Tomokazu Ito, Hiroe Takada, Keiko Isobe, Masataka Suzuki, Yasuyuki Kitaura, Hisashi Hemmi, Tsukasa Matsuda, Jumpei Sasabe, Tohru Yoshimura

研究成果: Article査読

抄録

D-Serine is an endogenous coagonist for N-methyl-. d-aspartate (NMDA) receptors and is involved in excitatory neurotransmission. Excessive receptor activation causes excitotoxicity, leading to various acute and chronic neurological disorders. Decrease in d-serine content may provide a therapeutic strategy for the treatment of the neurological disorders in which overstimulation of NMDA receptors plays a pathological role. Saccharomyces cerevisiae d-serine dehydratase (Dsd1p), which acts dominantly on d-serine, may be a useful d-serine reducing agent. We conjugated a linear 5-kDa polyethylene glycol (PEG) to Dsd1p (PEG-Dsd1p) and examined the effects of PEG-conjugation on its biochemical and pharmacokinetic properties. PEG-Dsd1p retained activity, specificity, and stability of the enzyme. The PEG modification extended the serum half-life of Dsd1p in mice 6-fold, from 3.8. h to 22.4. h. PEG-Dsd1p was much less immunogenic compared to the unmodified enzyme. Intraperitoneal administration of PEG-Dsd1p was effective in decreasing the d-serine content in the mouse hippocampus. These findings suggest that PEG-Dsd1p may be a novel tool for lowering d-serine levels in vivo.

本文言語English
ページ(範囲)34-39
ページ数6
ジャーナルJournal of Pharmaceutical and Biomedical Analysis
116
DOI
出版ステータスPublished - 2015 12月 10

ASJC Scopus subject areas

  • 分析化学
  • 薬科学
  • 創薬
  • 分光学
  • 臨床生化学

フィンガープリント

「PEGylated d-serine dehydratase as a d-serine reducing agent」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル